Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY47.26 CNY
Change Today -1.55 / -3.18%
Volume 1.6M
600436 On Other Exchanges
Symbol
Exchange
Shanghai
As of 11:13 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

zhangzhou pientzehuang pha-a (600436) Snapshot

Open
CNY47.50
Previous Close
CNY48.81
Day High
CNY47.59
Day Low
CNY46.00
52 Week High
06/4/15 - CNY98.56
52 Week Low
09/22/14 - CNY32.52
Market Cap
19.0B
Average Volume 10 Days
4.4M
EPS TTM
CNY1.32
Shares Outstanding
402.2M
EX-Date
06/4/15
P/E TM
35.7x
Dividend
CNY0.36
Dividend Yield
0.76%
Current Stock Chart for ZHANGZHOU PIENTZEHUANG PHA-A (600436)

Related News

No related news articles were found.

zhangzhou pientzehuang pha-a (600436) Related Businessweek News

No Related Businessweek News Found

zhangzhou pientzehuang pha-a (600436) Details

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. produces and sells Chinese patent medicines in China, Southeast Asia, Japan, Korea, Canada, and other countries. The company provides medicine and health products primarily in the areas of cough and cold relief, liver protection, woman and children products, and cardiovascular diseases, as well as offers cosmetics and chemicals. The company is based in Zhangzhou, China.

zhangzhou pientzehuang pha-a (600436) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhangzhou pientzehuang pha-a (600436) Key Developments

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Proposes Amendment to its Articles of Association

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. held the directorate meeting on August 24, 2015 to discuss and approve proposal of amendment to articles of association.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Half of 2015

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. reported earnings results for the first half of 2015. For the period, the company ported basic earnings per share of CNY 0.63 and weighted average return on net assets of 8.31%.

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd., Board Meeting, Aug 24, 2015

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd., Board Meeting, Aug 24, 2015. Agenda: To discuss and approve the semi-annual report of 2015 and its abstract, the proposal of special report on deposit and actual usage of raised funds in first half of 2015 and the proposal of amendment to articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600436:CH CNY47.26 CNY -1.55

600436 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600436.
View Industry Companies
 

Industry Analysis

600436

Industry Average

Valuation 600436 Industry Range
Price/Earnings 45.5x
Price/Sales 14.2x
Price/Book 7.1x
Price/Cash Flow 45.6x
TEV/Sales 13.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHANGZHOU PIENTZEHUANG PHA-A, please visit www.zzpzh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.